(Q51035665)

27 March 2018

title

p53-independent anti-tumor effects of the nitrogen-containing bisphosphonate zoledronic acid. (English)

1 reference

27 March 2018

author

Oliver Ottmann

10

1 reference

27 March 2018

author name string

Junya Kuroda

1

1 reference

27 March 2018

Shinya Kimura

2

1 reference

27 March 2018

Hidekazu Segawa

3

1 reference

27 March 2018

Kiyoshi Sato

4

1 reference

27 March 2018

Seiji Matsumoto

5

1 reference

27 March 2018

Masaki Nogawa

6

1 reference

27 March 2018

Takeshi Yuasa

7

1 reference

27 March 2018

Yutaka Kobayashi

8

1 reference

27 March 2018

Toshikazu Yoshikawa

9

1 reference

27 March 2018

Taira Maekawa

11

1 reference

27 March 2018

publication date

1 February 2004

1 reference

27 March 2018

published in

Cancer Science

1 reference

27 March 2018

volume

95

1 reference

27 March 2018

issue

2

1 reference

27 March 2018

page(s)

186-192

1 reference

27 March 2018

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

The epidermal growth factor receptor-tyrosine kinase: a promising therapeutic target in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

Blocking oncogenic Ras signaling for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

Inhibition of Ras prenylation: a novel approach to cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph+ leukemia activity of imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

Bisphosphonates induce apoptosis in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

Effects of caffeine on the uncoupling protein family in obese yellow KK mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

Mutations in the p53 gene occur in diverse human tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

A new bisphosphonate, YM529 induces apoptosis in HL60 cells by decreasing phosphorylation of single survival signal ERK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

Proteasome inhibitors induced caspase-dependent apoptosis and accumulation of p21WAF1/Cip1 in human immature leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death: evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B/Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

Rap1 mediates sustained MAP kinase activation induced by nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

P53: an ubiquitous target of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

Induction of p57(KIP2) expression by p73beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

Decreased expression of p57(KIP2)mRNA in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

A pro-apoptotic effect of the CDK inhibitor p57(Kip2) on staurosporine-induced apoptosis in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

Green tea polyphenols induce differentiation and proliferation in epidermal keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

The pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with varying degrees of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03202.X

10.1111/J.1349-7006.2004.TB03202.X

21 January 2018

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018